aspartyllysine has been researched along with Lymphoma* in 1 studies
1 other study(ies) available for aspartyllysine and Lymphoma
Article | Year |
---|---|
Synthesis and activity of NAcSerAspLysPro analogues on cellular interactions between T-cell and erythrocytes in rosette formation.
Analogues of NAcSerAspLysPro (AcSDKP), a natural regulator of hematopoiesis isolated from fetal calf bone marrow, were synthesized. The biological activity of these molecules were evaluated in vitro in the rosette assay, which measures the interaction between human Jurkat T-cells and sheep red blood cells. In this test, the tripeptide SerAspLys was the most efficient. Inhibitory activity was detected at the concentration 10(-14) M for the analogue and at 10(-9) M for the parent tetrapeptide. The dipeptide NAcSerAsp still showed activity but at much higher doses (10(-6) M). Substitution of polar amino acids led mostly to inactive molecules. Thus, replacement of Ser by Ala, or Lys by Orn yielded completely inactive compounds and replacement of Asp by Glu decreased the activity (10(-6) M). The present study gives an insight into the role of individual amino acids of AcSDKP in the inhibition of the rosette formation which implicates interactions with T-cell CD2 glycoprotein. Topics: Amino Acid Sequence; Animals; Biological Assay; Chemical Phenomena; Chemistry; Erythrocytes; Hematopoiesis; Humans; Lymphoma; Molecular Sequence Data; Oligopeptides; Rosette Formation; Sheep; Structure-Activity Relationship; T-Lymphocytes; Tumor Cells, Cultured | 1990 |